MEN 2019: 16th International Workshop on Multiple Endocrine Neoplasia
A Focus on New Concepts and Treatment of Malignant Manifestations
March 26-29, 2019
The University of Texas MD Anderson Cancer Center
Duncan Building (CPB) Floor 8, Rooms 1-8
1155 Pressler St.
Houston, Texas 77030
16.50 AMA PRA Category 1 CreditsTM
This conference should be of value to clinicians (including physicians, nurse practitioners, physician assistants and genetic counselors), researchers and trainees (students, residents, and fellows).
Agendas are subject to change because we are always striving to improve the quality of your educational experience. MD Anderson may substitute faculty with comparable expertise on rare occasions necessitated by illness, schedule conflicts and so forth.
Please let us know what specific topics, issues or questions you wish to see addressed or emphasized in this activity. Fax CME/Conference Management at 713-794-1724 or email firstname.lastname@example.org. All responses will be forwarded to the Program Chair for consideration.
In keeping with the spirit of the original MEN workshop, MEN2019 will focus on emerging topics in the genesis and therapy of malignant endocrine tumors associated with multiple endocrine neoplasia. The goal of the workshop will be to provide an outline for basic and clinical research focused on these malignant manifestations. The meeting will bring together local and international experts on multiple endocrine neoplasia to focus on
A significiant portion of the meeting will be spent in workshops centered on emerging topics and the development of an international roadmap for future research and clinical trials.
The remainder of the meeting will be composed of large group didactic sessions. The University of Texas MD Anderson Cancer Center is a leader in the development of new therapies for cancer. Our goal is to combine the extensive local scientific and clinical talent at MD Anderson along with international experts to allow focus on emerging topics including new directions in immunotherapy, emerging concepts in the use of signaling pathway inhibitors, genetic diagnosis & therapy and new clinical advances that impact management of endocrine tumor syndromes.
A specific outcome of this conference will be a white paper summarizing the goals of this work.
After attending the conference, participants should be able to:
- Identify and utilize alternative therapies to the traditional targeted therapy for the treatment of medullary thyroid cancer that may benefit their patients (Knowledge, Competence, Performance);
- Gain an awareness of modern therapy for pancreatic neuroendocrine tumors so that the most efficacious therapy may be delivered (Knowledge, Competence, Performance, Patient Outcomes);
- Utilize options to treat symptoms ofexcessive hormonal secretion in patientswith malignant pheochromocytoma andparaganglioma (Knowledge, Competence,Performance);
- Understand menin function and telomerebiology in pancreatic neuroendocrinetumors (Knowledge);
- Appreciate the clinical trials availablefor patients with parathyroid cancer andenroll them appropriately (Knowledge, Competence, Performance);
- Understand basic, clinical, and translationalgenetics with regard to TP53 germline (Knowledge).
- Poster Session
- Interactive Groups/Breakouts
A conference evaluation link will be included in the final program. This online survey will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations
as well as to identify future educational topics.
The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 16.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME Certificates andAttendance Verification Certificates
Certificates awarding AMA PRA Category1 Credit™ or certificates documentingattendance will be emailed when an individual completes the online CME Verification process.
Faculty Disclosures: In compliance with the requirements of ASHA’s Continuing Education Board concerning transparency in course planning, delivery, and marketing, disclosures are available at www.mdanderson.org/conferences.
The University of Texas MD Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented. MD Anderson also requires that all faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity.
Physician Payments Sunshine Act
MD Anderson complies with the Physician Payments Sunshine Act as part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfer of value provided to any covered recipient under the ACA.
Deadline for Abstract Submission is Monday, January 7, 2019.
The Planning Committee invites the submission of abstracts. The goal is to provide the audience an opportunity to collaborate and stimulate discussions specifically on emerging topics in the genesis and therapy of malignant endocrine tumors associated with multiple endocrine neoplasia.
Authors may submit abstracts of completed work, work in progress, or work presented elsewhere.
Abstract Submission Instructions:
Abstracts will only be accepted electronically and should be uploaded to: MEN2019@mdanderson.org.
Six abstracts will be chosen for an oral presentation. The remainder of the selected abstracts will be presented in a poster session.
The deadline for receipt of abstracts is 11:59 PM CST on Monday, January 7. Notification of acceptance for oral and/or poster presentations will be acknowledged by e-mail by Wednesday, January 23, 2019.
Abstract Formatting Instructions:
Please indicate in your abstract whether you would like to be considered for an oral presentation, a poster or both. 200 word limit. Limit abstracts to one page, type in 12-point Times New Roman font, single spaced with one-inch margins, and left justified. Organize the abstract into: Background, Methods, Results, and Conclusions. Define all abbreviations. Include the abstract title, full names, and institutional affiliations of all authors, and e-mail address of the corresponding author at the top of the abstract. Underline the name of the presenting author. Abstracts must not contain copyrighted material unless permission has been obtained by the author/publisher.
Early registration and a Welcome Reception begin at 5:30 pm on Tuesday, March 26. On-site registration will begin at 7:00 am on Wednesday, March 27 and the Welcome and Introductions will begin at 8:00 am.
Advanced registration is encouraged as space and materials are limited.
Early Bird Registration Fee (before February 15, 2019)..........$600.00
Late Registration Fee (after February 15, 2019)..........$700.00
MD Anderson Faculty/Staff..........$200.00
MD Anderson Trainees..........$50.00
Space Center Houston Dinner Ticket (evening of March 28, 2019)..........$85.00/person (Roundtrip transportation included)
We sincerely hope you can join us for dinner at Space Center Houston on Thursday, March 28, 2019.
Space Center Houston is the Official Visitor Center of NASA Johnson Space Center, the home of astronaut training, International Mission Control and human space exploration.
Dinner will be held in the Astronaut Gallery beginning at 6:30 pm. You will be able to see the ejection suit that astronaut John Young wore on the first shuttle flight in 1981 along with the T-38 flight suit worn by our second female astronaut and fallen hero, Judy Resnik. You’ll also have an opportunity to see a Saturn V rocket; the tallest, heaviest and most powerful rocket ever brought to operational status and responsible for launching astronauts to the moon. You won’t want to miss this unique experience!
Other Ways to Register
CME/Conference Management, Unit 1781
The University of Texas MD Anderson Cancer Center
P.O. Box 301407
Houston, TX 77230-1707
Fax to: 713-794-1724 (Printable Form)
We accept the following forms of payment:
- Check (payable through U.S. banks only)
- Money Order
- Credit Cards (MasterCard, VISA and American Express)
- Cash (on-site registration only)
If you register online, a receipt/confirmation letter will be automatically emailed to the email address you list on the registration form. If you register by fax or mail, a receipt/confirmation letter will be sent to you within 10 working days of the receipt of your fee.
The registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before February 15, 2019. No refunds will be granted after that date. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check.
CME/Conference Management reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, e-mail, or the contact numbers as given on the registration form. In case of activity cancellation, liability of the CME/Conference Management is limited to the registration fee. CME/Conference Management will refund the full registration fee.
CME/Conference Management reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available.
For additional information, please contact CME/Conference Management at 713-792-2223 or toll free at 866-849-5866.
- A block of rooms has been reserved for conference attendees at the Wyndham Houston – Medical Center located at 6800 South Main Street, Houston, Texas 77030.
- Early hotel reservation is suggested and the room block cutoff date is: Tuesday, March 5, 2019.
- The hotel phone number is 713-528-7744
- When you make reservations, be sure to mention the group name: Multiple Endocrine Neoplasia 2019 room block to be assured of receiving the special meeting rate of $165 for a single or double guest room. Please add 17% Texas state and local taxes.
- Houston is served by two airports, George Bush Intercontinental (IAH) and William P. Hobby (HOU).
- Taxicabs are available at an estimated cost for $50-60, to or from William P. Hobby Airport or George Bush Intercontinental Airport.
- Super Shuttle operates a shuttle bus between George Bush Intercontinental Airport and the Wyndham Houston Medical Center for $27 one-way and $54 round-trip. For more information, call 713-523-8888 or toll-free at 800-258-3826 or online at www.supershuttle.com.
- Super Shuttle operates a shuttle bus between William P. Hobby Airport and the Wyndham Houston Medical Center for $24 one-way and $48 round-trip. For more information, call 713-523-8888 or toll-free at 800-258-3826 or online at www.supershuttle.com.
Mays Garage Parking:
MD Anderson employees are encouraged to park in their normal location; however parking is available at the Mays Clinic garage.
Use Entrance 5 at Holcombe Boulevard at Bertner Avenue to access the garage beneath the Mays Clinic Building. Mays Clinic is adjacent to the conference site, Duncan Building (CPB). Mays Clinic self-parking is $12 per day and valet parking is $15 per day.
From the garage, take the elevators to the second floor and follow the hallway signs to the Duncan Building. After you pass Cool Beans Café on your left, take the Q Elevator Bank , also located on your left, to the Conference Center on the eighth floor.
Photographing, audio taping and videotaping are prohibited.